Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade

Reference:
Product namePinatuzumab Biosimilar - Anti-CD22 mAb - Research Grade
SourceCAS 1313706-14-7
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsPinatuzumab,ACD22-VCMMAE,DCDT2980S,FCU2803,RG-7593,RO5541072-000,CD22,anti-CD22
ReferencePX-TA1316
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Pinatuzumab Biosimilar - Anti-CD22 mAb - Research Grade

General information on Anti-CD22[Homo sapiens] (Pinatuzumab) Monoclonal Antibody

Pinatuzumab is investigated for the treatment of Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD223 Recombinant Protein
Antigen

CD223 Recombinant Protein

PX-P4110 310€
Interferon-induced transmembrane protein 1(IFITM1)
Antigen

Interferon-induced transmembrane protein 1(IFITM1)

PX-P4692 210€
SIGLEC2 recombinant protein
Antigen

SIGLEC2 recombinant protein

PX-P5177 385€
IGF1R recombinant protein
Antigen

IGF1R recombinant protein

PX-P5185 385€
CD223 / LAG3, C-His, recombinant protein
Antigen

CD223 / LAG3, C-His, recombinant protein

PX-P5592 385€
Stable Isotope Labelled Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade
SIL

Stable Isotope Labelled Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade

PX-TA1316-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products